VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
NBTXNanobiotix S.A.
$35.23$1.7B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksNBTXEarnings History

NBTX logoNanobiotix S.A. (NBTX) Earnings History

Net Loss

14 years of earnings data (2011–2024) · Currently unprofitable on a TTM basis

TTM Net Income
-$85M
● Net Loss
TTM EPS (Diluted)
$-1.79
Per share, diluted
YoY EPS Growth
-33.3%
Declining
Net Margin
586.9%
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating Margin589.1%
Gross Margin100.0%
Return on EquityN/A
Return on Assets-84.5%
Record Annual Net Income-$5MFY2011
Record Quarterly EPS$-0.11Q2 2025
Consecutive Profitable Years0years
Q2 2025
Net Income-$5M
EPS (Diluted)$-0.11
YoY Growth-33.3%Declining
QoQ Growth+88.4%Excellent

Loading earnings history...

Nanobiotix S.A. (NBTX) Earnings Overview

As of June 23, 2026, Nanobiotix S.A. (NBTX) reported trailing twelve-month net income of -$85M, reflecting -33.3% year-over-year growth. The company earned $-1.79 per diluted share over the past four quarters, with a net profit margin of 586.9%.

Looking at the long-term picture, NBTX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$5M in fiscal 2011.

Nanobiotix S.A. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including NVCR (-$173M net income, -20.8% margin), ARAY (-$46M net income, -0.3% margin), SENS (-$87M net income, -196.0% margin), NBTX has outperformed on profitability metrics. Compare NBTX vs NVCR →

NBTX Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
NBTX logoNBTXCurrent
-$85M$-1.79586.9%--33.3%—
NVCR logoNVCR
-$173M$-1.52-20.8%-38.9%+21.8%
ARAY logoARAY
-$46M$-0.37-0.3%-2.5%+90.3%
SENS logoSENS
-$87M$-1.90-196.0%-310.7%+33.6%
ONCO logoONCO
-$10M$-15.44-1721.0%-110.6%+99.1%
CELC logoCELC
-$193M$-3.54--163.8%-33.6%
Best in group
Lowest in group

NBTX Historical Earnings Data (2011–2024)

14 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2024-$68M-71.6%-$68M$-1.44--
2023-$40M+30.4%-$27M$-1.08-109.6%-74.0%
2022-$57M-21.4%-$47M$-1.64-1194.4%-977.8%
2021-$47M-39.8%-$53M$-1.35-1775.7%-1986.4%
2020-$34M+34.0%-$36M$-1.38-67246.0%-72856.0%
2019-$51M-70.3%-$47M$-2.35-74875.0%-68792.6%
2018-$30M-14.4%-$30M$-1.52-25772.4%-25919.8%
2017-$26M-19.5%-$25M$-1.50-10375.6%-10027.9%
2016-$22M-28.7%-$22M$-1.43-1404.3%-1402.6%
2015-$17M-77.9%-$17M$-1.20-6403.1%-6455.3%
2014-$10M-17.3%-$10M$-0.74-987.8%-994.3%
2013-$8M-52.8%-$8M$-0.76-4404.1%-4422.8%
2012-$5M-1.6%-$5M$-0.65-7189.0%-6948.9%
2011-$5M--$5M$-3.42-385.7%-384.3%

Download Data

Export NBTX earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

15+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

NBTX — Frequently Asked Questions

Quick answers to the most common questions about buying NBTX stock.

What is NBTX earnings per share (EPS)?

NBTX trailing twelve-month (TTM) diluted EPS is $-1.79, reflecting -33.3% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2011 to 2024 is available in the table on this page.

What is Nanobiotix S.A.'s net income?

Nanobiotix S.A. (NBTX) trailing twelve-month net income is $-85M as of 2024. Earnings declined -33.3% year-over-year.

Is NBTX profitable?

NBTX is not currently profitable on a TTM basis, reporting a net loss of $-85M. Net margin is +586.9%. Investors should monitor for a return to profitability.

What is NBTX's earnings growth rate?

NBTX compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2011 to 2024.

What are NBTX's profit margins?

Nanobiotix S.A. net profit margin is +586.9%, operating margin is +589.1%, and gross margin is +100.0%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is N/A.

Is NBTX growing earnings?

NBTX earnings are declining — EPS fell -33.3% year-over-year. TTM net income dropped to $-85M. This contrasts with the 5-year CAGR of N/A.

What was NBTX's best earnings year?

Nanobiotix S.A.'s highest annual net income on record is $-5M, achieved in fiscal year 2011. Earnings history on this page spans 2011 to 2024 and includes all annual and quarterly figures.

What were NBTX's earnings last quarter?

NBTX's most recent reported quarter was Q2 2025. Net income was $-5M with diluted EPS of $-0.11. For a full breakdown of all quarters, see the quarterly earnings table on this page.

NBTX Earnings Over Time (2011–2024)

Net income & EPS — annual and quarterly view